Enamine Ltd was founded in 1991 with the advent of high throughput screening in early drug discovery. In over 15 years Enamine has become a global provider of Screening Compounds, Building Blocks, and Fragments for supporting a wide range of research programs conducted by pharmaceutical and biotech companies, drug discovery centres, academic institutions, and other research organizations worldwide.